Heritage Wealth Advisors Natera, Inc. Transaction History

Heritage Wealth Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$30.32 - $91.33 $454 - $1,369	-15 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$100.17 - $126.36 $30,051 - $37,908	-300 Reduced 95.24%	15 $1,000
Q2 2021 Aug 09, 2021	SELL	$86.05 - $119.72 $46,467 - $64,648	-540 Reduced 63.16%	315 $35,000
Q2 2021 Jul 27, 2021	BUY	$86.05 - $119.72 $46,467 - $64,648	540 Added 171.43%	855 $85,000
Q1 2021 Apr 27, 2021	SELL	$91.47 - $124.36 $49,393 - $67,154	-540 Reduced 63.16%	315 $31,000
Q4 2020 Feb 01, 2021	BUY	$66.66 - $111.74 $8,999 - $15,084	135 Added 18.75%	855 $85,000
Q2 2020 Jul 17, 2020	BUY	$26.36 - $49.86 $15,605 - $29,517	592 Added 462.5%	720 $35,000
Q2 2020 Jul 17, 2020	SELL	$26.36 - $49.86 $15,605 - $29,517	-592 Reduced 82.22%	128 $35,000
Q1 2020 May 05, 2020	BUY	$17.27 - $40.17 $725 - $1,687	42 Added 6.19%	720 $21,000
Q4 2019 Feb 04, 2020	BUY	$32.1 - $40.4 $1,701 - $2,141	53 Added 8.48%	678 $22,000
Q1 2019 May 06, 2019	BUY	$11.34 - $20.62 $7,087 - $12,887	625 New	625 $0

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Heritage Wealth Advisors with notifications on news.